Passer au contenu principal

fms related receptor tyrosine kinase 4

La FLT4 gene provides instructions for making a protein called vascular endothelial growth factor receptor 3 (VEGFR-3), which regulates the development and maintenance of the lymphatic system. The lymphatic system produces and transports fluids and immune cells throughout the body. VEGFR-3 is turned on (activated) by two proteins called vascular endothelial growth factor C (VEGF-C) and vascular endothelial growth factor D (VEGF-D). When VEGF-C and VEGF-D attach (bind) to VEGFR-3, chemical signals are produced that regulate the growth, movement, and survival of lymphatic cells.

Sélections vidéo pour Gènes
Bibliothèque vidéo

Normal function

La FLT4 gene provides instructions for making a protein called vascular endothelial growth factor receptor 3 (VEGFR-3), which regulates the development and maintenance of the lymphatic system. The lymphatic system produces and transports fluids and immune cells throughout the body. VEGFR-3 is turned on (activated) by two proteins called vascular endothelial growth factor C (VEGF-C) and vascular endothelial growth factor D (VEGF-D). When VEGF-C and VEGF-D attach (bind) to VEGFR-3, chemical signals are produced that regulate the growth, movement, and survival of lymphatic cells.

Conditions referring to this gene or chromosome

Other names

FLT41

fms-related tyrosine kinase 4

vascular endothelial growth factor receptor 3

VEGFR3

VGFR3_HUMAN

Related patient information and medicines

Cancer de la bouche

Patient information leaflet

Cancer de la bouche

Epidermal growth factor receptor monoclonal antibody (EGFR mAb) is one form of targeted therapy. Cetuximab is an EGFR mAb. Tyrosine kinase inhibitors (TKIs) are another. Immunotherapy is treatment that aims to boost the body's own immune system to destroy the cancer cells. It is also sometimes called biological therapy: Recombinant interleukin.

Leucémie myéloïde chronique

Patient information leaflet

Leucémie myéloïde chronique

Treatment for the initial chronic phase The aim of treatment is to control the disease process, to ease any symptoms and to prevent (or delay) the progress... You may be advised to have one or more of the following treatments: Imatinib tablets. This medicine is known as a tyrosine kinase inhibitor. The chemical tyrosine kinase is made by the.

Mastocytose et troubles des mastocytes

Patient information leaflet

Mastocytose et troubles des mastocytes

If the condition is severe, surgery to remove the spleen (splenectomy), medicines that have an effect on ... Dr Sarah Jarvis , 28th September 2021 Midostaurin for treating advanced systemic mastocytosis The National Institute for Health and Care Excellence (NICE) has brought out new guidance on the use of midostaurin for people with mastocytosis..

Fibromyalgie

Patient information leaflet

Fibromyalgie

Fibromyalgie est a condition which causes pain and tenderness in the muscles and soft tissues in different areas of the body, associated with unrefreshing sleep and physical tiredness. The word fibromyalgie means pain (-algia) coming from the muscles (my-) and fibrous tissues (fibro-) such as tendons and ligaments. Due to its wide range of.

Dégénérescence maculaire

Patient information leaflet

Dégénérescence maculaire

It is more common with increasing age. It is rare under the age of 60. It usually begins in one eye. About 5 in 100 people aged over 65 and about 12 in 100 people aged over 80 have AMD severe enough to cause serious visual impairment. Women are more likely than men to develop AMD. White people are more likely to develop AMD than those of African.

Tests de fonction hépatique

Patient information leaflet

Tests de fonction hépatique

They include substances that are made in the liver or affected by the health of the liver cells, chemicals which are processed or excreted by the liver, and hormones that the liver makes. What are liver function tests used for. Liver function tests are aimed at giving a picture of the 'state' of your liver. They are a sensitive way of looking for.

Lectures complémentaires et références

Historique de l'article

Les informations sur cette page sont rédigées et examinées par des cliniciens qualifiés.
  • 28 Jun 2022 | Dernière version
  • 1 May 2008 | Publié à l'origine

Participez à la conversation

Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.

Avertissement : The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Pharmacie en ligne, traitements et services de santé

Accès simple à des traitements fiables et à des services de santé en ligne.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Inscrivez-vous à la newsletter Patient

Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.

Veuillez entrer une adresse e-mail valide

En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.